Rapid detection of tuberculosis and drug-resistant tuberculosis

New England Journal of Medicine

Volumn 355, Issue 15, 2006, Pages 1606-1608

  Iseman, Michael D ^a   Heifets, Leonid B ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; DRUG SENSITIVITY; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; TUBERCULOSIS;

BACTERIOLOGICAL TECHNIQUES; DIFFUSION OF INNOVATION; HUMANS; LABORATORIES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; ORGANIZATIONAL INNOVATION; SPECIMEN HANDLING; SPUTUM; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 33749627319     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe068173     Document Type: Editorial

References (6)

1. Heifets LB, Cangelosi GA. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tuberc Lung Dis 1999;3:564-81.
2. Moore DAJ, Evans CAW, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006;355:1539-50.
3. Caviedes L, Lee TS, Gilman RH, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol 2000;38:1203-8.
4. Moore DA, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 2004;42:4432-7.
5. Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Atlanta: Centers for Disease Control, 1985.
6. Heifets LB, Richmond JY. Modern biological safety standards in tuberculosis diagnostic (TB) laboratories. In: Richmond JY, ed. Anthology in biosafety. IX. Exploring the performance envelope for BSL-3 and BSL-4 laboratories. Mundelein, IL: American Biological Safety Association, 2006:155-66.